Coast To Coast Tribune
SEE OTHER BRANDS

The latest news from the United States

Coast To Coast Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Coast To Coast Tribune.

Press releases published on April 2, 2025

Duluth Holdings Inc. Announces Stephanie Pugliese as President and CEO

Duluth Holdings Inc. Announces Stephanie Pugliese as President and CEO

MOUNT HOREB, Wis., April 02, 2025 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel, and accessories, …

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

PLANO, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior …

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors

WEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the …

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. FibroGen’s management team will be …

BBSI Announces Appointment of Thomas McGinn as Senior Vice President of Insurance

BBSI Announces Appointment of Thomas McGinn as Senior Vice President of Insurance

VANCOUVER, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business management solutions, today announced the appointment of Thomas McGinn as Senior Vice President of Insurance. In this …

Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Compass Therapeutics to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the …

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted eight newly-hired employees options to purchase …

GRI Bio Announces Closing of $5.0 Million Public Offering

GRI Bio Announces Closing of $5.0 Million Public Offering

LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and …

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced fourth quarter financial …

NeuroPace Announces Refocusing of Product Portfolio

NeuroPace Announces Refocusing of Product Portfolio

-- Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 -- -- Maintaining 2025 Revenue Guidance -- -- No Change to Long-Range Plan Expectations of Cash Flow Breakeven by the end of 2027 and Achievement of 20%+ Revenue CAGR -- …

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

Terns Pharmaceuticals Reports Inducement Grant to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

Introduction of EluPro at Heart Rhythm 2025 in San Diego, April 25-27, 2025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, is proud to announce …

Alpine Income Property Trust Announces First Quarter 2025 Transaction Activity and Balance Sheet Update

Alpine Income Property Trust Announces First Quarter 2025 Transaction Activity and Balance Sheet Update

WINTER PARK, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) today announced its investment and disposition activities for the first quarter of 2025 and provided a balance sheet update. Investment …

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14

KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on …

Digital Brands Group Inc. Acquires Assets of Open Daily Technologies Inc., a Virtual Shopping Innovation Company

Digital Brands Group Inc. Acquires Assets of Open Daily Technologies Inc., a Virtual Shopping Innovation Company

Austin, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (OTC Markets: DBGI), a publicly traded company specializing in eCommerce and Fashion, today announced that it has acquired the assets of Open Daily Technologies Inc. (“Open Daily …

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday, April 23, 2025, after the New York Stock Exchange …

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential …

FormFactor Doubles Capacity at Taiwan Service Center to Meet Growing Demand

FormFactor Doubles Capacity at Taiwan Service Center to Meet Growing Demand

LIVERMORE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leading provider of test and measurement technologies for the semiconductor industry, is pleased to announce the significant expansion of its Taiwan Service Center. …

BioCryst to Present at Upcoming Investor Conference

BioCryst to Present at Upcoming Investor Conference

RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, at 9:30 a …

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service